Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
2
×
life sciences
national blog main
new york blog main
san diego blog main
san diego top stories
achaogen
adams street partners
akcea therapeutics
antibiotics
anylam pharmaceuticals
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech
boston blog main
boston top stories
cardiomyopathy
deals
drug resistance
fda
hatteras venture partners
inotersen
investing
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
national top stories
neuropathy
new enterprise associates
new york
new york top stories
onpattro
patisiran
pfizer
rempex pharmaceuticals
san diego
spero therapeutics
What
disease
2
×
drug
medicines
2
×
year
ago
akcea
alnylam
amyloidosis
approved
attr
available
bacteria
battle
biopharma
business
company
debilitating
exited
fda
fighting
genetic
infections
infectious
launches
melinta
oks
patients
pfizer
products
qpex
rare
resistant
sets
sold
tackle
therapeutics
transthyretin
Language
Current search:
medicines
×
drugs
×
disease
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections